CORPORATE

First shipments of plasma from Porto and Lisbon were received in the beginning of February

Guaranteeing equitable access to treatment is the central theme of the 2022 edition

Exclusive agreement signed for the distribution of a novel iron-based therapy

The project supported by Kedrion defines some of the key principles intended to improve patient envolvement

Scope is supplying Immunoglobulins to meet patient demand in France

Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency

Thirty patients aged 2 to 17yo to be enrolled over five European countries

Agreement with Canadian-based Liminal BioSciences signed on June 22nd

The initiative aims to promote the training of new generations of clinicians in the field of liver transplantation